577P Updated analysis of phase I dose-escalation and dose cohort expansion studies of senaparib (IMP4297) in Chinese patients with advanced solid tumours

B Xu,C Junning,H Guo,P Zhang,Y Zhou,R Zhang,J Dongmei,W Shen,S Cai,Y.E Tian,C-Y Hsieh,C Xu,N Ma,Y Chen,S Yang,S Zhang

doi:10.1016/j.annonc.2020.08.691

577P Updated analysis of phase I dose-escalation and dose cohort expansion studies of senaparib (IMP4297) in Chinese patients with advanced solid tumours

B Xu, C Junning + Show 14 more

Open Access

https://doi.org/10.1016/j.annonc.2020.08.691

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2020
Citations: 2	License type: elsevier-specific: oa user license

Affiliation: Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University Shanghai Cancer Center, Nanjing Drum Tower Hospital, Fudan University

#Advanced Solid Tumours #Chinese Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

577P Updated analysis of phase I dose-escalation and dose cohort expansion studies of senaparib (IMP4297) in Chinese patients with advanced solid tumours

Full Text